Ignite Creation Date:
2025-12-25 @ 4:47 AM
Ignite Modification Date:
2026-01-25 @ 6:36 PM
Study NCT ID:
NCT01462318
Status:
COMPLETED
Last Update Posted:
2017-03-14
First Post:
2011-07-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
An Open-Label Immunogenicity and Pharmacokinetics Study of Daclizumab High Yield Process Prefilled Syringe in Relapsing Remitting Multiple Sclerosis
Sponsor:
Organization: